Look for:

Our offer for

VERTEX PHARMACEUTICALS INC.


ISIN:
US92532F1003
WKN:
92532F100
2024/05/21 16:32:10
Price
443.1958 USD
Difference 2.85% (12.27)

General attributes

ISINUS92532F1003
SymbolVRTX
ExchangeLondon Stock Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)105,082 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open443.1958 USD
High443.1958 USD
Low443.1958 USD
Close (prev. day)430.93 USD
VWAP443.19583 USD
Volume (pcs)155
Trading volume45,649.17
Number of trades8
Last size103

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: VERTEX PHARMACEUTICALS INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/05/21 16:32:10
Price
443.1958 USD
Difference 2.85% (12.27)

General attributes

ISINUS92532F1003
SymbolVRTX
ExchangeLondon Stock Exchange
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)105,082 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)-
Ask (Ask size)-
Open443.1958 USD
High443.1958 USD
Low443.1958 USD
Close (prev. day)430.93 USD
VWAP443.19583 USD
Volume (pcs)155
Trading volume45,649.17
Number of trades8
Last size103

Performance and Risk

6m1Y3Y
Perf (%)---
Perf (abs.)---
Beta0.720.670.60
Volatility1.742.453.44
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)437.0629 USD (90)
Ø price 30 days | Ø volume 30 days (pcs.)413.6476 USD (123)
Ø price 100 days | Ø volume 100 days (pcs.)417.4606 USD (857)
Ø price 250 days | Ø volume 250 days (pcs.)376.1627 USD (972)
YTD High | date443.1958 USD (2024/05/21)
YTD Low | date395.1700 USD (2024/04/26)
52 Weeks High | date443.1958 USD (2024/05/21)
52 Weeks Low | date324.4700 USD (2023/06/01)

All listings for VERTEX PHARMACEUTICALS INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Berlin2024/05/2208:08406.20 EUR0.001
Duesseldorf2024/05/2212:30407.20 EUR0.003
Euronext Milan MTF Global Equity Market2024/05/2117:44406.15 EUR0.001
Euronext Milan MTF Trading After Hours2024/04/2920:01371.75 EUR0.001
Frankfurt2024/05/2208:02406.20 EUR0.001
Hamburg2024/05/2208:14406.40 EUR0.001
Hanover2024/05/2208:14406.40 EUR0.001
London Stock Exchange2024/05/2116:32443.1958 USD0.058
Munich2024/05/2208:01406.15 EUR0.001
Nasdaq2024/05/2122:00442.00 USD488.4029,877
Stuttgart2024/05/2208:01406.25 EUR0.001
Tradegate2024/05/2212:38408.10 EUR0.026
Vienna Stock Exchange2024/05/2209:05407.20 EUR0.001
Xetra2024/05/2117:35406.55 EUR0.015

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=15368&ID_TYPE_IMAGE_LOGO=2

Contact Details

VERTEX PHARMACEUTICALS INC.
- -
50 Northern Avenue - 02210 Boston
Telefon: +1-617-341-6100
Fax: +
E-mail: mediainfo@vrtx.com

PDF Downloads

Company report: VERTEX PHARMACEUTICALS INC.PDF Download

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Members of Management Board

Jeffrey LeidenChairman of Board of Directors
Alan GarberMember of Board of Directors
Jennifer SchneiderMember of Board of Directors
Sangeeta BhatiaMember of Board of Directors
Bruce SachsMember of Board of Directors
Diana McKenzieMember of Board of Directors
Lloyd CarneyMember of Board of Directors
Michel LagardeMember of Board of Directors
Nancy ThornberryMember of Board of Directors
Suketu UpadhyayMember of Board of Directors
Reshma KewalramaniChairman of Managing Board
David AltshulerMember of Executive Committee
Amit K. SachdevMember of Executive Committee
Bastiano SannaMember of Executive Committee
Carmen BozicMember of Executive Committee
Charles F. WagnerMember of Executive Committee
E. Morrey AtkinsonMember of Executive Committee
Jonathan BillerMember of Executive Committee
Nia TatsisMember of Executive Committee
Stuart A. ArbuckleMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer